Document_and_Entity_Informatio
Document and Entity Information | 6 Months Ended | |
Mar. 31, 2015 | Apr. 30, 2015 | |
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | FALSE | |
Document Period End Date | 31-Mar-15 | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | NUAN | |
Entity Registrant Name | Nuance Communications, Inc. | |
Entity Central Index Key | 1002517 | |
Current Fiscal Year End Date | -21 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 313,828,530 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Revenues: | ||||
Product and licensing | $174,451 | $174,819 | $344,139 | $353,256 |
Professional services and hosting | 224,504 | 227,526 | 450,674 | 445,661 |
Maintenance and support | 76,104 | 73,308 | 154,265 | 146,716 |
Total revenues | 475,059 | 475,653 | 949,078 | 945,633 |
Cost of revenues: | ||||
Product and licensing | 23,252 | 25,226 | 47,222 | 50,435 |
Professional services and hosting | 151,021 | 157,437 | 308,264 | 312,017 |
Maintenance and support | 13,395 | 12,359 | 27,436 | 25,196 |
Amortization of intangible assets | 15,631 | 15,342 | 30,762 | 30,536 |
Total cost of revenues | 203,299 | 210,364 | 413,684 | 418,184 |
Gross profit | 271,760 | 265,289 | 535,394 | 527,449 |
Operating expenses: | ||||
Research and development | 74,776 | 84,581 | 157,343 | 165,051 |
Sales and marketing | 93,254 | 98,280 | 204,504 | 217,186 |
General and administrative | 45,734 | 43,682 | 96,301 | 88,158 |
Amortization of intangible assets | 25,328 | 26,571 | 52,155 | 54,043 |
Acquisition-related costs, net | 6,523 | 6,802 | 11,279 | 9,600 |
Restructuring and other charges, net | -333 | 4,719 | 1,895 | 8,556 |
Total operating expenses | 245,282 | 264,635 | 523,477 | 542,594 |
Income (loss) from operations | 26,478 | 654 | 11,917 | -15,145 |
Other income (expense): | ||||
Interest income | 627 | 774 | 1,189 | 1,193 |
Interest expense | -30,034 | -33,987 | -59,931 | -67,946 |
Other income (expense), net | -110 | -274 | -895 | -3,370 |
Loss before income taxes | -3,039 | -32,833 | -47,720 | -85,268 |
Provision for income taxes | 11,059 | 6,394 | 16,873 | 9,372 |
Net loss | ($14,098) | ($39,227) | ($64,593) | ($94,640) |
Net loss per share: | ||||
Basic (in dollars per share) | ($0.04) | ($0.12) | ($0.20) | ($0.30) |
Diluted (in dollars per share) | ($0.04) | ($0.12) | ($0.20) | ($0.30) |
Weighted average common shares outstanding: | ||||
Basic (in shares) | 322,879 | 316,593 | 322,331 | 315,696 |
Diluted (in shares) | 322,879 | 316,593 | 322,331 | 315,696 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Net loss | ($14,098) | ($39,227) | ($64,593) | ($94,640) |
Other comprehensive (loss) income: | ||||
Foreign currency translation adjustment | -49,522 | -1,127 | -77,740 | 5,477 |
Defined Benefit Plan, Amortization of Gains (Losses) | -759 | 0 | ||
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax | -734 | 0 | ||
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax | 58 | 0 | 29 | 0 |
Total other comprehensive (loss) income, net | -50,223 | -1,127 | -78,445 | 5,477 |
Comprehensive loss | ($64,321) | ($40,354) | ($143,038) | ($89,163) |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $474,650 | $547,230 |
Available-for-sale Securities, Current | 63,044 | 40,974 |
Accounts receivable, less allowances for doubtful accounts of $12,204 and $11,491 | 394,054 | 428,266 |
Prepaid expenses and other current assets | 92,118 | 92,040 |
Deferred tax assets | 56,128 | 55,990 |
Total current assets | 1,079,994 | 1,164,500 |
Available-for-sale Securities, Noncurrent | 29,228 | 0 |
Land, building and equipment, net | 185,985 | 191,411 |
Goodwill | 3,354,734 | 3,410,893 |
Intangible assets, net | 852,561 | 915,483 |
Other assets | 147,325 | 137,997 |
Total assets | 5,649,827 | 5,820,284 |
Current liabilities: | ||
Current portion of long-term debt | 4,834 | 4,834 |
Contingent And Deferred Acquisition Payments | 8,556 | 35,911 |
Accounts payable | 58,053 | 61,760 |
Accrued expenses and other current liabilities | 180,003 | 241,279 |
Deferred revenue | 343,651 | 298,225 |
Total current liabilities | 595,097 | 642,009 |
Long-term debt | 2,137,738 | 2,127,392 |
Deferred revenue, net of current portion | 294,154 | 249,879 |
Deferred tax liabilities | 162,499 | 156,235 |
Other liabilities | 58,753 | 62,777 |
Total liabilities | 3,248,241 | 3,238,292 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value; 560,000 shares authorized; 321,784 and 324,621 shares issued and 318,034 and 320,870 shares outstanding, respectively | 322 | 325 |
Additional paid-in capital | 3,151,882 | 3,153,033 |
Treasury stock, at cost (3,751 shares) | -16,788 | -16,788 |
Accumulated other comprehensive loss | -102,460 | -24,015 |
Accumulated deficit | -631,370 | -530,563 |
Total stockholders’ equity | 2,401,586 | 2,581,992 |
Total liabilities and stockholders’ equity | $5,649,827 | $5,820,284 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
In Thousands, except Per Share data, unless otherwise specified | ||
Accounts receivable, allowances for doubtful accounts | $12,204 | $11,491 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 560,000 | 560,000 |
Common stock, shares issued | 321,784 | 324,621 |
Common stock, shares outstanding | 318,034 | 320,870 |
Treasury stock, shares | 3,751 | 3,751 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 6 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Cash flows from operating activities: | ||
Net loss | ($64,593) | ($94,640) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 114,020 | 109,417 |
Stock-based compensation | 78,271 | 92,159 |
Non-cash interest expense | 14,918 | 19,443 |
Deferred tax provision | 6,386 | 3,446 |
Other | 1,427 | -5,258 |
Changes in operating assets and liabilities, net of effects from acquisitions: | ||
Accounts receivable | 16,988 | 6,518 |
Prepaid expenses and other assets | -13,213 | -11,695 |
Accounts payable | 1,869 | -32,097 |
Accrued expenses and other liabilities | -50,017 | -10,301 |
Deferred revenue | 109,575 | 88,190 |
Net cash provided by operating activities | 215,631 | 165,182 |
Cash flows from investing activities: | ||
Capital expenditures | -30,758 | -24,719 |
Payments for business and technology acquisitions, net of cash acquired | -31,891 | -135,537 |
Payments to Acquire Investments | 91,348 | 11,504 |
Proceeds from sales and maturities of marketable securities and other investments | 23,165 | 21,634 |
Net cash used in investing activities | -130,832 | -150,126 |
Cash flows from financing activities: | ||
Payments of debt | -2,418 | -2,516 |
Payments for repurchase of common stock | -109,838 | -26,435 |
Payments for settlement of share-based derivatives | -340 | -5,286 |
Repayments of Other Long-term Debt | -1,526 | -1,519 |
Proceeds from issuance of common stock from employee stock plans | 9,149 | 11,922 |
Cash used to net share settle employee equity awards | -46,953 | -31,047 |
Net cash used in financing activities | -151,926 | -54,881 |
Effects of exchange rate changes on cash and cash equivalents | -5,453 | 9 |
Net decrease in cash and cash equivalents | -72,580 | -39,816 |
Cash and cash equivalents at beginning of period | 547,230 | 808,118 |
Cash and cash equivalents at end of period | $474,650 | $768,302 |
Organization_and_Presentation
Organization and Presentation | 6 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Presentation | Organization and Presentation |
The consolidated financial statements include the accounts of Nuance Communications, Inc. (“Nuance”, “we”, or “the Company”) and our wholly-owned subsidiaries. We prepared these unaudited interim consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP) for interim periods. In our opinion, these financial statements reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of our financial position for the periods disclosed. Intercompany transactions have been eliminated. | |
Although we believe the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in the footnotes prepared in accordance with GAAP has been omitted. Accordingly, these financial statements should be read in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014. Interim results are not necessarily indicative of the results that may be expected for a full year. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 6 Months Ended |
Mar. 31, 2015 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies |
Effective October 1, 2014, we implemented Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists", which did not have a significant impact on our consolidated financial statements. | |
We have made no material changes to the significant accounting policies disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014. | |
Recently Issued Accounting Standards | |
In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." The amendments in the ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amendments are effective for us in the first quarter of fiscal 2017, with early adoption permitted. The amendments should be applied on a retrospective basis to each individual period presented. Upon implementation, the change in reporting debt issuance costs will require us to reclassify our deferred financing costs from an asset to a reduction of the reported debt balance. This will reduce our assets and liabilities but will have no impact on earnings, cash flows or shareholders' equity. | |
In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Amendments to the Consolidation Analysis.” The amendments in this update provide guidance on evaluating whether a company should consolidate certain legal entities. In accordance with the guidance, all legal entities are subject to reevaluation under the revised consolidation model. The pronouncement is effective for us in the first quarter of fiscal 2017 with early adoption permitted. We do not believe that this will have a material impact on our consolidated financial statements. | |
In August 2014, the FASB issued Accounting Standards Update No. 2014-15, "Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" (ASU 2014-15), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in the first quarter of fiscal 2017, with early adoption permitted. We do not believe that this will have a material impact on our consolidated financial statements. | |
In June 2014, the FASB issued Accounting Standards Update No. 2014-12, "Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period" (ASU 2014-12). ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in ASC 718, "Compensation - Stock Compensation," as it relates to such awards. ASU 2014-12 is effective for us in our first quarter of fiscal 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. We are currently evaluating the impact of our pending adoption on ASU 2014-12 on our consolidated financial statements. | |
In May 2014, the FASB issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers: Topic 606" (ASU 2014-09), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for us in our first quarter of fiscal 2018 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU 2014-09. We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements. | |
In April 2014, the FASB issued Accounting Standards Update No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" (ASU 2014-08), to change the criteria for determining which disposals can be presented as discontinued operations and enhanced the related disclosure requirements. ASU 2014-08 is effective for us on a prospective basis in our first quarter of fiscal 2016 with early adoption permitted for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. We are currently evaluating the impact of our pending adoption of ASU 2014-08 on our consolidated financial statements. |
Business_Acquisitions
Business Acquisitions | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Business Combinations [Abstract] | ||||||||||||||||
Business Acquisitions | Business Acquisitions | |||||||||||||||
During the first six months of fiscal 2015, we have not made any material acquisitions. | ||||||||||||||||
During fiscal 2014, we acquired several immaterial businesses in our Imaging, Healthcare and Enterprise segments for total initial cash consideration of $258.3 million together with future contingent payments. In allocating the total purchase consideration for these acquisitions based on preliminary estimated fair values, we recorded $139.4 million of goodwill and $134.5 million of identifiable intangibles assets. Intangible assets acquired included customer relationships and core and completed technology with weighted average useful lives of 10.2 years. The most significant of these acquisitions are treated as stock purchases, and the goodwill resulting from these acquisitions is not expected to be deductible for tax purposes. | ||||||||||||||||
The fair value estimates for the assets acquired and liabilities assumed for acquisitions completed during fiscal 2014 were based upon preliminary calculations and valuations, and our estimates and assumptions for each of these acquisitions are subject to change as we obtain additional information during the respective measurement periods (up to one year from the respective acquisition dates). The primary areas of preliminary estimates that were not yet finalized related to certain assets and liabilities acquired. There were no significant changes to the fair value estimates during the current year. | ||||||||||||||||
Acquisition-Related Costs, net | ||||||||||||||||
Acquisition-related costs include costs related to business and other acquisitions, including potential acquisitions. These costs consist of (i) transition and integration costs, including retention payments, transitional employee costs and earn-out payments treated as compensation expense, as well as the costs of integration-related activities including services provided by third-parties; (ii) professional service fees, including third party costs related to the acquisitions, and legal and other professional service fees associated with disputes and regulatory matters related to acquired entities; and (iii) adjustments to acquisition-related items that are required to be marked to fair value each reporting period, such as contingent consideration, and other items related to acquisitions for which the measurement period has ended. | ||||||||||||||||
The components of acquisition-related costs, net are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Transition and integration costs | $ | 2,756 | $ | 4,590 | $ | 6,237 | $ | 8,429 | ||||||||
Professional service fees | 3,485 | 2,399 | 5,686 | 5,738 | ||||||||||||
Acquisition-related adjustments | 282 | (187 | ) | (644 | ) | (4,567 | ) | |||||||||
Total | $ | 6,523 | $ | 6,802 | $ | 11,279 | $ | 9,600 | ||||||||
Included in acquisition-related adjustments for the six months ended March 31, 2014, is income of $7.7 million related to the elimination of contingent liabilities established in the original allocation of purchase price for acquisitions closed in fiscal 2008, following the expiration of the applicable statute of limitations. |
Goodwill_and_Intangible_Assets
Goodwill and Intangible Assets | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||
Goodwill and Intangible Assets | Goodwill and Intangible Assets | |||||||
The changes in the carrying amount of goodwill and intangible assets for the six months ended March 31, 2015, are as follows (dollars in thousands): | ||||||||
Goodwill | Intangible | |||||||
Assets | ||||||||
Balance at September 30, 2014 | $ | 3,410,893 | $ | 915,483 | ||||
Acquisitions | — | 27,830 | ||||||
Purchase accounting adjustments | (1,788 | ) | (554 | ) | ||||
Amortization | — | (82,917 | ) | |||||
Effect of foreign currency translation | (54,371 | ) | (7,281 | ) | ||||
Balance at March 31, 2015 | $ | 3,354,734 | $ | 852,561 | ||||
In October 2014, we realigned certain of our product offerings among reporting units. As required by Accounting Standards Codification 350-20, "Intangibles - Goodwill and Other", we have reallocated goodwill among the affected reporting units, based on their relative fair value. We reallocated $29.9 million of goodwill from our Dragon Consumer reporting unit into our Mobile reporting unit, and reallocated $10.5 million of goodwill from our Mobile reporting unit to our Enterprise reporting unit. As a result of this change, we determined that we had a triggering event requiring us to perform an impairment test on our Dragon Consumer ("DNS"), Mobile, and Enterprise reporting units. We completed our impairment test during the first quarter of fiscal 2015, and the fair value of the reorganized reporting units substantially exceeded their carrying values. |
Financial_Instruments_and_Hedg
Financial Instruments and Hedging Activities | 6 Months Ended | ||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||
Financial Instruments and Hedging Activities | Financial Instruments and Hedging Activities | ||||||||||||||||||
Derivatives Not Designated as Hedges | |||||||||||||||||||
Forward Currency Contracts | |||||||||||||||||||
We operate our business in countries throughout the world and transact business in various foreign currencies. Our foreign currency exposures typically arise from transactions denominated in currencies other than the functional currency of our operations. We have a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effect of certain foreign currency exposures. Our program is designed so that increases or decreases in our foreign currency exposures are offset by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with our foreign currency transactions. Generally we enter into such contracts for less than 90 days, and at March 31, 2015 and September 30, 2014, we had outstanding contracts with a total notional value of $141.4 million and $283.1 million, respectively. | |||||||||||||||||||
We have not designated these forward contracts as hedging instruments pursuant to ASC 815, Derivatives and Hedging, and accordingly, we record the fair value of these contracts at the end of each reporting period in our consolidated balance sheet, with changes in the fair value recorded in earnings as other income (expense), net in our consolidated statements of operations. | |||||||||||||||||||
Security Price Guarantees | |||||||||||||||||||
From time to time we enter into agreements that allow us to issue shares of our common stock as part or all of the consideration related to business acquisitions, partnering and technology acquisition activities. Some of these shares are issued subject to security price guarantees, which are accounted for as derivatives. We have determined that these instruments would not be considered equity instruments if they were freestanding. Certain of the security price guarantees require payment from either us to a third party, or from a third party to us, based upon the difference between the price of our common stock on the issue date and an average price of our common stock approximately six months following the issue date. We have also issued minimum price guarantees that may require payments from us to a third party based on the average share price of our common stock approximately six months following the issue date if our stock price falls below the minimum price guarantee. Changes in the fair value of these security price guarantees are reported in earnings in each period as other income (expense), net in our consolidated statements of operations. | |||||||||||||||||||
The following is a summary of the outstanding shares subject to security price guarantees at March 31, 2015 (dollars in thousands): | |||||||||||||||||||
Issue Date | Number of Shares Issued | Settlement Date | Total Value of Shares on Issue Date | ||||||||||||||||
November 10, 2014 | 288,148 | May 12, 2015 | $ | 4,469 | |||||||||||||||
The following table provides a quantitative summary of the fair value of our derivative instruments as of March 31, 2015 and September 30, 2014 (dollars in thousands): | |||||||||||||||||||
Derivatives Not Designated as Hedges: | Balance Sheet Classification | Fair Value | |||||||||||||||||
31-Mar-15 | 30-Sep-14 | ||||||||||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | $ | 379 | $ | — | ||||||||||||||
Foreign currency contracts | Accrued expenses and other current liabilities | (383 | ) | (272 | ) | ||||||||||||||
Security Price Guarantees | Contingent and deferred acquisition payments | (334 | ) | — | |||||||||||||||
Security Price Guarantees | Accrued expenses and other current liabilities | — | (135 | ) | |||||||||||||||
Net fair value of non-hedge derivative instruments | $ | (338 | ) | $ | (407 | ) | |||||||||||||
The following tables summarize the activity of derivative instruments for the three and six months ended March 31, 2015 and 2014 (dollars in thousands): | |||||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | ||||||||||||||||||
Derivatives Not Designated as Hedges | Location of Gain (Loss) Recognized in Income | 2015 | 2014 | 2015 | 2014 | ||||||||||||||
Foreign currency contracts | Other income (expense), net | $ | (12,813 | ) | $ | 2,046 | $ | (19,096 | ) | $ | 6,372 | ||||||||
Security price guarantees | Other income (expense), net | $ | 23 | $ | (72 | ) | $ | (539 | ) | $ | (4,222 | ) | |||||||
Other Financial Instruments | |||||||||||||||||||
Financial instruments including cash equivalents, accounts receivable and accounts payable are carried in the consolidated financial statements at amounts that approximate their fair value based on the short maturities of those instruments. Marketable securities and derivative instruments are carried at fair value. | |||||||||||||||||||
The estimated fair value of our long-term debt approximated $2,220.2 million (face value $2,215.0 million) and $2,179.2 million (face value $2,217.4 million) at March 31, 2015 and September 30, 2014, respectively. These fair value amounts represent the value at which our lenders could trade our debt within the financial markets and do not represent the settlement value of these long-term debt liabilities to us at each reporting date. The fair value of the long-term debt issues will continue to vary each period based on fluctuations in market interest rates, as well as changes to our credit ratings. The Senior Notes, the term loan portion of our Credit Facility, and the Convertible Debentures are traded and the fair values of each borrowing was estimated using the averages of the bid and ask trading quotes at each respective reporting date. We had no outstanding balance on the revolving credit line portion of our Credit Facility at March 31, 2015 or September 30, 2014. |
Fair_Value_Measures
Fair Value Measures | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||
Fair Value Measures | Fair Value Measures | |||||||||||||||
Fair value is defined as the price that would be received for an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Valuation techniques must maximize the use of observable inputs and minimize the use of unobservable inputs. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. | ||||||||||||||||
ASC 820, Fair Value Measures and Disclosures, establishes a value hierarchy based on three levels of inputs, of which the first two are considered observable and the third is considered unobservable: | ||||||||||||||||
• | Level 1. Quoted prices for identical assets or liabilities in active markets which we can access. | |||||||||||||||
• | Level 2. Observable inputs other than those described as Level 1. | |||||||||||||||
• | Level 3. Unobservable inputs. | |||||||||||||||
Assets and liabilities measured at fair value on a recurring basis at March 31, 2015 and September 30, 2014 consisted of (dollars in thousands): | ||||||||||||||||
31-Mar-15 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 275,478 | $ | — | $ | — | $ | 275,478 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Time deposits | — | 53,190 | — | 53,190 | ||||||||||||
Commercial paper, $9,080 at cost (b) | — | 9,087 | — | 9,087 | ||||||||||||
Corporate notes and bonds, $41,838 at cost (b) | — | 41,860 | — | 41,860 | ||||||||||||
Foreign currency exchange contracts(b) | — | 379 | — | 379 | ||||||||||||
Total assets at fair value | $ | 276,478 | $ | 104,516 | $ | — | $ | 380,994 | ||||||||
Liabilities: | ||||||||||||||||
Foreign currency exchange contracts(b) | $ | — | $ | (383 | ) | $ | — | $ | (383 | ) | ||||||
Security price guarantees(c) | — | (334 | ) | — | (334 | ) | ||||||||||
Contingent acquisition payments (d) | — | — | (3,931 | ) | (3,931 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (717 | ) | $ | (3,931 | ) | $ | (4,648 | ) | |||||
30-Sep-14 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 407,749 | $ | — | $ | — | $ | 407,749 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Time deposits(b) | — | 46,604 | — | 46,604 | ||||||||||||
Total assets at fair value | $ | 408,749 | $ | 46,604 | $ | — | $ | 455,353 | ||||||||
Liabilities: | ||||||||||||||||
Foreign currency exchange contracts(b) | $ | — | $ | (272 | ) | $ | — | $ | (272 | ) | ||||||
Security price guarantees(c) | — | (135 | ) | — | (135 | ) | ||||||||||
Contingent acquisition payments (d) | — | — | (6,864 | ) | (6,864 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (407 | ) | $ | (6,864 | ) | $ | (7,271 | ) | |||||
(a) | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||||||||||||||
(b) | The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||||||||||||||
(c) | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | |||||||||||||||
(d) | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. | |||||||||||||||
Time deposits are generally for terms of one year or less. The commercial paper and corporate notes and bonds mature within three years and have a weighted average maturity of 1.31 years. | ||||||||||||||||
The changes in the fair value of contingent acquisition payment liabilities are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2015 | |||||||||||||||
Balance at beginning of period | $ | 5,440 | $ | 6,864 | ||||||||||||
Earn-out liability established at time of acquisition | (554 | ) | 85 | |||||||||||||
Payments upon settlement | (1,476 | ) | (2,938 | ) | ||||||||||||
Adjustments to fair value included in acquisition-related costs, net | 521 | (80 | ) | |||||||||||||
Balance at end of period | $ | 3,931 | $ | 3,931 | ||||||||||||
Our financial liabilities valued based upon Level 3 inputs are composed of contingent consideration arrangements relating to our acquisitions. We are contractually obligated to pay contingent consideration to the selling shareholders upon the achievement of specified objectives, including the achievement of future bookings and sales targets related to the products of the acquired entities and therefore are recorded as contingent consideration liabilities at the time of the acquisitions. We update our assumptions each reporting period based on new developments and record such amounts at fair value based on the revised assumptions until the consideration is paid upon the achievement of the specified objectives or eliminated upon failure to achieve the specified objectives. | ||||||||||||||||
Contingent acquisition payment liabilities are scheduled to be paid in periods through fiscal 2016. As of March 31, 2015, we could be required to pay up to $16.0 million for contingent consideration arrangements if the specified objectives are achieved. We have determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are the estimated cash flows projected from future product sales and the risk adjusted discount rate for the fair value measurement. |
Accrued_Expenses_and_Other_Cur
Accrued Expenses and Other Current Liabilities | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Payables and Accruals [Abstract] | ||||||||
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities | |||||||
Accrued expenses and other current liabilities consisted of the following (dollars in thousands): | ||||||||
31-Mar-15 | 30-Sep-14 | |||||||
Compensation | $ | 91,455 | $ | 146,730 | ||||
Cost of revenue related liabilities | 19,632 | 22,340 | ||||||
Accrued interest payable | 15,106 | 15,092 | ||||||
Liability for unsettled share repurchases | 10,465 | — | ||||||
Professional fees | 9,844 | 10,852 | ||||||
Sales and marketing incentives | 8,006 | 10,188 | ||||||
Sales and other taxes payable | 5,916 | 9,367 | ||||||
Acquisition costs and liabilities | 5,494 | 9,307 | ||||||
Facilities related liabilities | 5,207 | 5,720 | ||||||
Other | 8,878 | 11,683 | ||||||
Total | $ | 180,003 | $ | 241,279 | ||||
Deferred_Revenue
Deferred Revenue | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Deferred Revenue [Abstract] | ||||||||
Deferred Revenue | Deferred Revenue | |||||||
Deferred maintenance revenue consists of prepaid fees received for post-contract customer support for our products, including telephone support and the right to receive unspecified upgrades/updates on a when-and-if-available basis. Unearned revenue includes upfront fees for setup and implementation activities related to hosted offerings; certain software arrangements for which we do not have fair value of post-contract customer support, resulting in ratable revenue recognition for the entire arrangement on a straight-line basis; and fees in excess of estimated earnings on percentage-of-completion service contracts. | ||||||||
Deferred revenue consisted of the following (dollars in thousands): | ||||||||
31-Mar-15 | 30-Sep-14 | |||||||
Current liabilities: | ||||||||
Deferred maintenance revenue | $ | 150,983 | $ | 140,737 | ||||
Unearned revenue | 192,668 | 157,488 | ||||||
Total current deferred revenue | $ | 343,651 | $ | 298,225 | ||||
Long-term liabilities: | ||||||||
Deferred maintenance revenue | $ | 58,412 | $ | 60,398 | ||||
Unearned revenue | 235,742 | 189,481 | ||||||
Total long-term deferred revenue | $ | 294,154 | $ | 249,879 | ||||
Restructuring_and_Other_Charge
Restructuring and Other Charges, net | 6 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||
Restructuring and Related Activities Disclosure [Text Block] | Restructuring and Other Charges, net | |||||||||||||||||||||||
Restructuring and other charges, net include restructuring expenses together with other expenses that are unusual in nature and are the result of unplanned events, and arise outside of the ordinary course of continuing operations. Restructuring expenses consist of employee severance costs and may also include charges for duplicate facilities and other contract termination costs. Other amounts may include gains or losses on non-controlling strategic equity interests, and gains or losses on sales of non-strategic assets or product lines. | ||||||||||||||||||||||||
The following table sets forth accrual activity relating to our restructuring reserves for the six months ended March 31, 2015 (dollars in thousands): | ||||||||||||||||||||||||
Personnel | Facilities | Total | ||||||||||||||||||||||
Balance at September 30, 2014 | $ | 3,258 | $ | 1,468 | $ | 4,726 | ||||||||||||||||||
Restructuring charges, net | 1,639 | 256 | 1,895 | |||||||||||||||||||||
Cash payments | (4,191 | ) | (1,372 | ) | (5,563 | ) | ||||||||||||||||||
Balance at March 31, 2015 | $ | 706 | $ | 352 | $ | 1,058 | ||||||||||||||||||
Restructuring charges, net by segment are as follows (dollars in thousands): | ||||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | (81 | ) | $ | — | $ | (81 | ) | $ | 186 | $ | — | $ | 186 | ||||||||||
Mobile and Consumer | (125 | ) | (172 | ) | (297 | ) | (12 | ) | — | (12 | ) | |||||||||||||
Enterprise | 71 | — | 71 | 1,568 | — | 1,568 | ||||||||||||||||||
Imaging | (1 | ) | (60 | ) | (61 | ) | 131 | — | 131 | |||||||||||||||
Corporate | 35 | — | 35 | (199 | ) | 45 | (154 | ) | ||||||||||||||||
Total restructuring expense | $ | (101 | ) | $ | (232 | ) | $ | (333 | ) | $ | 1,674 | $ | 45 | $ | 1,719 | |||||||||
Included in restructuring charges, net for the three months ended March 31, 2015, is the benefit resulting from lower charges than originally estimated related to final settlement on abandoned facilities. | ||||||||||||||||||||||||
Six Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | (209 | ) | $ | — | $ | (209 | ) | $ | 400 | $ | — | $ | 400 | ||||||||||
Mobile and Consumer | (113 | ) | (172 | ) | (285 | ) | 190 | — | 190 | |||||||||||||||
Enterprise | 289 | 95 | 384 | 1,745 | — | 1,745 | ||||||||||||||||||
Imaging | 1,479 | 333 | 1,812 | 131 | — | 131 | ||||||||||||||||||
Corporate | 193 | — | 193 | 627 | 2,463 | 3,090 | ||||||||||||||||||
Total restructuring expense | $ | 1,639 | $ | 256 | $ | 1,895 | $ | 3,093 | $ | 2,463 | $ | 5,556 | ||||||||||||
For the six months ended March 31, 2015, we recorded net restructuring charges of $1.9 million, which included a $1.6 million severance charge related to the elimination of approximately 60 personnel to eliminate duplicative positions resulting from acquisitions, and $0.3 million primarily resulting from the restructuring of facilities that will no longer be utilized. |
Debt_and_Credit_Facilities
Debt and Credit Facilities | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Debt and Credit Facilities | Debt and Credit Facilities | |||||||
At March 31, 2015 and September 30, 2014, we had the following borrowing obligations (dollars in thousands): | ||||||||
31-Mar-15 | 30-Sep-14 | |||||||
5.375% Senior Notes due 2020, net of unamortized premium of $4.2 million and $4.6 million, respectively. Effective interest rate 5.28%. | $ | 1,054,209 | $ | 1,054,601 | ||||
2.75% Convertible Debentures due 2031, net of unamortized discount of $75.7 million and $88.8 million, respectively. Effective interest rate 7.43%. | 614,280 | 601,226 | ||||||
Credit Facility, net of unamortized original issue discount of $0.9 million and $1.0 million respectively. | 474,083 | 476,399 | ||||||
Total long-term debt | $ | 2,142,572 | $ | 2,132,226 | ||||
Less: current portion | 4,834 | 4,834 | ||||||
Non-current portion of long-term debt | $ | 2,137,738 | $ | 2,127,392 | ||||
2.75% Convertible Debentures due 2031 | ||||||||
As of March 31, 2015 and September 30, 2014, none of the conversion criteria were met for the 2031 Debentures. If the conversion criteria were met, we could be required to repay all or some of the principal amount in cash prior to maturity. | ||||||||
Credit Facility | ||||||||
The Credit Facility includes a term loan and a $75 million revolving credit line, including letters of credit. The term loan matures on August 7, 2019 and the revolving credit line matures on August 7, 2018. As of March 31, 2015, there were $5.4 million of letters of credit issued, and there were no other outstanding borrowings under the revolving credit line. | ||||||||
Under the terms of the amended and restated credit agreement, interest is payable monthly at a rate equal to the applicable margin plus, at our option, either (a) the base rate which is the corporate base rate of Morgan Stanley, the Administrative Agent, or (b) LIBOR (equal to (i) the British Bankers’ Association Interest Settlement Rates for deposits in U.S. dollars divided by (ii) one minus the statutory reserves applicable to such borrowing). The applicable margin for the borrowings at March 31, 2015 is as follows: | ||||||||
Description | Base Rate Margin | LIBOR Margin | ||||||
Term loans maturing August 2019 | 1.75% | 2.75% | ||||||
Revolving facility due August 2018 | 0.50% - 0.75% (a) | 1.50% - 1.75% (a) | ||||||
(a) | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. | |||||||
At March 31, 2015, the applicable margin for the term loans was 2.75%, with an effective rate of 2.93%, on the outstanding balance of $475.0 million maturing in August 2019. We are required to pay a commitment fee for unutilized commitments under the revolving credit facility at a rate ranging from 0.250% to 0.375% per annum, based upon our net leverage ratio. As of March 31, 2015, the commitment fee rate was 0.375%. | ||||||||
The Credit Facility contains covenants including, among other things, covenants that restrict our ability and those of our subsidiaries to incur certain additional indebtedness or issue guarantees, create or permit liens on assets, enter into sale-leaseback transactions, make loans or investments, sell assets, make certain acquisitions, pay dividends, repurchase stock, or merge or consolidate with any entity, and enter into certain transactions with affiliates. The agreement also contains events of default, including failure to make payments of principal or interest, failure to observe covenants, breaches of representations and warranties, defaults under certain other material indebtedness, failure to satisfy material judgments, a change of control and certain insolvency events. As of March 31, 2015, we were in compliance with the covenants under the Credit Facility. The covenants on our other long-term debt are less restrictive, and as of March 31, 2015, we were in compliance with the requirements of our other long-term debt. | ||||||||
Our obligations under the Credit Facility are unconditionally guaranteed by, subject to certain exceptions, each of our existing and future direct and indirect wholly-owned domestic subsidiaries. The Credit Facility and the guarantees thereof are secured by first priority liens and security interests in the following: 100% of the capital stock of substantially all of our domestic subsidiaries and 65% of the outstanding voting equity interests and 100% of the non-voting equity interests of first-tier foreign subsidiaries, all our material tangible and intangible assets and those of the guarantors, and any present and future intercompany debt. The Credit Facility also contains provisions for mandatory prepayments of outstanding term loans upon receipt of the following, and subject to certain exceptions: 100% of net cash proceeds from asset sales, 100% of net cash proceeds from issuance or incurrence of debt, and 100% of extraordinary receipts. We may voluntarily prepay borrowings under the Credit Facility without premium or penalty other than breakage costs, as defined with respect to LIBOR-based loans. | ||||||||
The Credit Facility includes a provision for an annual excess cash flow sweep, as defined in the agreement, payable in the first quarter of each fiscal year, based on the excess cash flow generated in the previous fiscal year. No excess cash flow sweep was required in the first quarter of fiscal 2015 as no excess cash flow, as defined in the agreement, was generated in fiscal 2014. At the current time, we are unable to predict the amount of the outstanding principal, if any, that we may be required to repay in future fiscal years pursuant to the excess cash flow sweep provisions. |
Stockholders_Equity_Notes
Stockholders' Equity (Notes) | 6 Months Ended |
Mar. 31, 2015 | |
Stockholders' Equity Attributable to Parent [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | Stockholders' Equity |
Share Repurchases | |
On April 29, 2013, our Board of Directors approved a share repurchase program for up to $500 million of our outstanding shares of common stock. Approximately $168.9 million remained available for share repurchases as of March 31, 2015 pursuant to our repurchase program. We repurchased 8.6 million shares for $120.3 million during the six months ended March 31, 2015. Since the commencement of the program, we have repurchased 20.0 million shares for $331.1 million. On April 29, 2015, our Board of Directors approved an additional $500 million under our share repurchase program. Under the terms of the repurchase program, we expect to continue to repurchase shares from time to time through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The timing and the amount of any purchases will be determined by management based on an evaluation of market conditions, capital allocation alternatives, and other factors. The share repurchase program does not require us to acquire any specific number of shares and may be modified, suspended, extended or terminated by us at any time without prior notice. |
Net_Loss_Per_Share
Net Loss Per Share | 6 Months Ended | |||
Mar. 31, 2015 | ||||
Earnings Per Share, Basic and Diluted [Abstract] | ||||
Net (Loss) Income Per Share | Net Loss Per Share | |||
Common equivalent shares are excluded from the computation of diluted net loss per share if their effect is anti-dilutive. Potentially dilutive common equivalent shares aggregating to 9.7 million and 12.5 million shares for the three months ended March 31, 2015 and 2014, respectively, and 11.2 million and 13.1 million shares for the six months ended March 31, 2015 and 2014, respectively, have been excluded from the computation of diluted net loss per share because their inclusion would be anti-dilutive. | ||||
StockBased_Compensation
Stock-Based Compensation | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Share-based Compensation [Abstract] | ||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation | |||||||||||||||
We recognize stock-based compensation expense over the requisite service period. Our share-based awards are accounted for as equity instruments. The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Cost of product and licensing | $ | 96 | $ | 697 | $ | 183 | $ | 962 | ||||||||
Cost of professional services and hosting | 4,729 | 7,199 | 12,352 | 13,818 | ||||||||||||
Cost of maintenance and support | 631 | 406 | 1,574 | 1,190 | ||||||||||||
Research and development | 6,668 | 10,455 | 17,177 | 20,743 | ||||||||||||
Selling and marketing | 7,882 | 10,210 | 20,416 | 25,454 | ||||||||||||
General and administrative | 10,911 | 15,953 | 26,569 | 29,992 | ||||||||||||
Total | $ | 30,917 | $ | 44,920 | $ | 78,271 | $ | 92,159 | ||||||||
Stock Options | ||||||||||||||||
The table below summarizes activity relating to stock options for the six months ended March 31, 2015: | ||||||||||||||||
Number of | Weighted | Weighted | Aggregate | |||||||||||||
Shares | Average | Average | Intrinsic | |||||||||||||
Exercise | Remaining | Value(a) | ||||||||||||||
Price | Contractual | |||||||||||||||
Term | ||||||||||||||||
Outstanding at September 30, 2014 | 3,723,342 | $ | 13.46 | |||||||||||||
Exercised | (98,845 | ) | $ | 2.03 | ||||||||||||
Forfeited | (892 | ) | $ | 20.04 | ||||||||||||
Expired | (29,248 | ) | $ | 20.38 | ||||||||||||
Outstanding at March 31, 2015 | 3,594,357 | $ | 13.72 | 1.8 years | $ | 4.7 | million | |||||||||
Exercisable at March 31, 2015 | 3,592,132 | $ | 13.71 | 1.8 years | $ | 4.7 | million | |||||||||
Exercisable at March 31, 2014 | 3,919,399 | $ | 13.39 | 2.6 years | $ | 15 | million | |||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on March 31, 2015 ($14.35) and the exercise price of the underlying options. | |||||||||||||||
The weighted-average intrinsic value of stock options exercised during the six months ended March 31, 2015 and 2014 was $1.2 million and $2.1 million, respectively. | ||||||||||||||||
Restricted Units | ||||||||||||||||
Restricted Units are not included in issued and outstanding common stock until the shares are vested and released. The purchase price for vested Restricted Units is $0.001 per share. The table below summarizes activity relating to Restricted Units for the six months ended March 31, 2015: | ||||||||||||||||
Number of Shares Underlying Restricted Units — Contingent Awards | Number of Shares Underlying Restricted Units — Time-Based Awards | |||||||||||||||
Outstanding at September 30, 2014 | 5,726,385 | 8,349,107 | ||||||||||||||
Granted | 1,312,530 | 5,551,512 | ||||||||||||||
Earned/released | (1,847,551 | ) | (5,604,407 | ) | ||||||||||||
Forfeited | (603,889 | ) | (321,467 | ) | ||||||||||||
Outstanding at March 31, 2015 | 4,587,475 | 7,974,745 | ||||||||||||||
Weighted average remaining recognition period of outstanding Restricted Units | 1.6 years | 1.6 years | ||||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Units | $57.6 million | $88.1 million | ||||||||||||||
Aggregate intrinsic value of outstanding Restricted Units(a) | $65.8 million | $114.5 million | ||||||||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on March 31, 2015 ($14.35) and the purchase price of the underlying Restricted Units. | |||||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Units vested during the periods noted is as follows: | ||||||||||||||||
Six Months Ended March 31, | ||||||||||||||||
2015 | 2014 | |||||||||||||||
Weighted-average grant-date fair value per share | $ | 14.87 | $ | 15.26 | ||||||||||||
Total intrinsic value of shares vested (in millions) | $ | 110.9 | $ | 70.2 | ||||||||||||
Restricted Stock Awards | ||||||||||||||||
Restricted Stock Awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to Restricted Stock Awards for the six months ended March 31, 2015: | ||||||||||||||||
Number of Shares Underlying Restricted Stock | Weighted Average Grant Date Fair Value | |||||||||||||||
Outstanding at September 30, 2014 | 750,000 | $ | 21.28 | |||||||||||||
Vested | (250,000 | ) | $ | 25.8 | ||||||||||||
Outstanding at March 31, 2015 | 500,000 | $ | 19.01 | |||||||||||||
Weighted average remaining recognition period of outstanding Restricted Awards | 0.6 years | |||||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Awards | $4.2 million | |||||||||||||||
Aggregate intrinsic value of outstanding Restricted Awards | $7.2 million | |||||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Stock Awards vested during the periods noted is as follows: | ||||||||||||||||
Six Months Ended March 31, | ||||||||||||||||
2015 | 2014 | |||||||||||||||
Weighted-average grant-date fair value per share | $ | — | $ | 15.71 | ||||||||||||
Total intrinsic value of shares vested (in millions) | $ | 3.9 | $ | 3.9 | ||||||||||||
Income_Taxes
Income Taxes | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Income Tax Disclosure [Abstract] | ||||||||||||||||
Income Taxes | Income Taxes | |||||||||||||||
The components of (loss) income before income taxes are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Domestic | $ | (37,225 | ) | $ | (55,683 | ) | $ | (100,935 | ) | $ | (121,628 | ) | ||||
Foreign | 34,186 | 22,850 | 53,215 | 36,360 | ||||||||||||
(Loss) income before income taxes | $ | (3,039 | ) | $ | (32,833 | ) | $ | (47,720 | ) | $ | (85,268 | ) | ||||
The components of provision from income taxes are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Domestic | $ | 5,832 | $ | 5,250 | $ | 9,634 | $ | 3,795 | ||||||||
Foreign | 5,227 | 1,144 | 7,239 | 5,577 | ||||||||||||
Provision for income taxes | $ | 11,059 | $ | 6,394 | $ | 16,873 | $ | 9,372 | ||||||||
Effective tax rate | (363.9 | )% | (19.5 | )% | (35.4 | )% | (11.0 | )% | ||||||||
The effective income tax rate was (363.9)% and (35.4)% for the three and six months ended March 31, 2015, respectively. Our current effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to current period losses in the U.S. that require an additional valuation allowance and provide no benefit to the provision. The three and six months ended March 31, 2015 also include$3.5 million and $7.1 million, respectively, of deferred tax expense related to tax deductible goodwill. In addition, included in the three and six months ended March 31, 2015 is a $2.5 million increase to the valuation allowance resulting from an allocation period adjustment related to an acquisition. Earnings in foreign operations are subject to a significantly lower tax rate than the U.S. statutory tax rate, driven primarily by our subsidiaries in Ireland. | ||||||||||||||||
Our effective income tax rate is based upon the income for the year, the composition of income in different countries, changes relating to valuation allowances for certain countries if and as necessary, and adjustments, if any, for potential tax consequences resulting from audits or other tax contingencies. Our aggregate income tax rate in foreign jurisdictions is lower than our income tax rate in the United States. Our effective tax rate may be adversely affected by earnings being lower than anticipated in countries where we have lower statutory tax rates and higher than anticipated in countries where we have higher statutory tax rates. | ||||||||||||||||
At March 31, 2015 and September 30, 2014, the liability for income taxes associated with uncertain tax positions was $22.1 million and $21.2 million, respectively, and is included in other long term liabilities. If these benefits were recognized, they would favorably impact the effective tax rate. We do not expect a significant change in the amount of unrecognized tax benefits within the next 12 months. |
Commitments_and_Contingencies
Commitments and Contingencies | 6 Months Ended |
Mar. 31, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies |
Litigation and Other Claims | |
Like many companies in the software industry, we are involved in a variety of claims, demands, suits, investigations and proceedings that arise from time to time relating to matters incidental to the ordinary course of our business, including actions with respect to contracts, intellectual property, employment, benefits and securities matters. We have estimated the amount of probable losses that may result from all currently pending matters, and such amounts are reflected in our consolidated financial statements. These recorded amounts are not material to our consolidated financial position or results of operations and no additional material losses related to these pending matters are reasonably possible. While it is not possible to predict the outcome of these matters with certainty, we do not expect the results of any of these actions to have a material adverse effect on our results of operations or financial condition. Because litigation is inherently unpredictable, however, the actual amounts of loss may prove to be larger or smaller than the amounts reflected in our consolidated financial statements, and we could incur judgments or enter into settlements of claims that could adversely affect our financial position, operating results or cash flows. | |
Guarantees and Other | |
We include indemnification provisions in the contracts we enter into with customers and business partners. Generally, these provisions require us to defend claims arising out of our products’ infringement of third-party intellectual property rights, breach of contractual obligations and/or unlawful or otherwise culpable conduct. The indemnity obligations generally cover damages, costs and attorneys’ fees arising out of such claims. In most, but not all cases, our total liability under such provisions is limited to either the value of the contract or a specified, agreed upon amount. In some cases our total liability under such provisions is unlimited. In many, but not all cases, the term of the indemnity provision is perpetual. While the maximum potential amount of future payments we could be required to make under all the indemnification provisions is unlimited, we believe the estimated fair value of these provisions is minimal due to the low frequency with which these provisions have been triggered. | |
We indemnify our directors and officers to the fullest extent permitted by Delaware law, which provides among other things, indemnification to directors and officers for expenses, judgments, fines, penalties and settlement amounts incurred by such persons in their capacity as a director or officer of the company, regardless of whether the individual is serving in any such capacity at the time the liability or expense is incurred. Additionally, in connection with certain acquisitions we have agreed to indemnify the former officers and members of the boards of directors of those companies, on similar terms as described above, for a period of six years from the acquisition date. In certain cases we purchase director and officer insurance policies related to these obligations, which fully cover the six year period. To the extent that we do not purchase a director and officer insurance policy for the full period of any contractual indemnification, and such directors and officers do not have coverage under separate insurance policies, we would be required to pay for costs incurred, if any, as described above. |
Segment_and_Geographic_Informa
Segment and Geographic Information and Significant Customers | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||
Segment and Geographic Information and Significant Customers | Segment and Geographic Information | |||||||||||||||
We operate in, and report financial information for, the following four reportable segments: Healthcare, Mobile and Consumer, Enterprise and Imaging. Segment profit is an important measure used for evaluating performance and for decision-making purposes and reflects the direct controllable costs of each segment together with an allocation of sales and corporate marketing expenses, and certain research and development project costs that benefit multiple product offerings. Segment profit represents income from operations excluding stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, costs associated with intellectual property collaboration agreements, other income (expense), net and certain unallocated corporate expenses. | ||||||||||||||||
In October 2014, we realigned certain of our product offerings which were previously reported in the Mobile and Consumer segment into the Enterprise segment. Accordingly, the segment results in prior periods have been reclassified to conform to the current period segment reporting presentation. | ||||||||||||||||
We do not track our assets by operating segment; consequently, it is not practical to show assets or depreciation by operating segment. The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Segment revenues(a): | ||||||||||||||||
Healthcare | $ | 228,604 | $ | 236,997 | $ | 459,584 | $ | 464,283 | ||||||||
Mobile and Consumer | 116,691 | 107,254 | 224,037 | 219,712 | ||||||||||||
Enterprise | 83,302 | 89,728 | 173,945 | 181,734 | ||||||||||||
Imaging | 59,466 | 55,994 | 119,527 | 114,289 | ||||||||||||
Total segment revenues | 488,063 | 489,973 | 977,093 | 980,018 | ||||||||||||
Acquisition-related revenues | (13,004 | ) | (14,320 | ) | (28,015 | ) | (34,385 | ) | ||||||||
Total consolidated revenues | 475,059 | 475,653 | 949,078 | 945,633 | ||||||||||||
Segment profit: | ||||||||||||||||
Healthcare | 79,842 | 91,477 | 158,120 | 169,937 | ||||||||||||
Mobile and Consumer | 33,816 | 16,697 | 45,509 | 28,830 | ||||||||||||
Enterprise | 19,282 | 18,230 | 44,014 | 40,673 | ||||||||||||
Imaging | 22,080 | 20,704 | 42,008 | 43,384 | ||||||||||||
Total segment profit | 155,020 | 147,108 | 289,651 | 282,824 | ||||||||||||
Corporate expenses and other, net | (35,450 | ) | (30,126 | ) | (71,118 | ) | (61,332 | ) | ||||||||
Acquisition-related revenues and cost of revenues adjustment | (12,088 | ) | (13,037 | ) | (26,378 | ) | (31,869 | ) | ||||||||
Stock-based compensation | (30,917 | ) | (44,920 | ) | (78,271 | ) | (92,159 | ) | ||||||||
Amortization of intangible assets | (40,959 | ) | (41,913 | ) | (82,917 | ) | (84,579 | ) | ||||||||
Acquisition-related costs, net | (6,523 | ) | (6,802 | ) | (11,279 | ) | (9,600 | ) | ||||||||
Restructuring and other charges, net | 333 | (4,719 | ) | (1,895 | ) | (8,556 | ) | |||||||||
Costs associated with IP collaboration agreements | (2,938 | ) | (4,937 | ) | (5,876 | ) | (9,874 | ) | ||||||||
Other expense, net | (29,517 | ) | (33,487 | ) | (59,637 | ) | (70,123 | ) | ||||||||
Loss before income taxes | $ | (3,039 | ) | $ | (32,833 | ) | $ | (47,720 | ) | $ | (85,268 | ) | ||||
(a) | Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. | |||||||||||||||
No country outside of the United States provided greater than 10% of our total revenue. Revenue, classified by the major geographic areas in which our customers are located, was as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
United States | $ | 352,448 | $ | 346,587 | $ | 700,122 | $ | 689,772 | ||||||||
International | 122,611 | 129,066 | 248,956 | 255,861 | ||||||||||||
Total revenues | $ | 475,059 | $ | 475,653 | $ | 949,078 | $ | 945,633 | ||||||||
Summary_of_Significant_Account1
Summary of Significant Accounting Policies Recently Issued Accounting Pronouncements (Tables) | 6 Months Ended |
Mar. 31, 2015 | |
Recently Issued Accounting Pronouncements [Abstract] | |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Issued Accounting Standards |
In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs." The amendments in the ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amendments are effective for us in the first quarter of fiscal 2017, with early adoption permitted. The amendments should be applied on a retrospective basis to each individual period presented. Upon implementation, the change in reporting debt issuance costs will require us to reclassify our deferred financing costs from an asset to a reduction of the reported debt balance. This will reduce our assets and liabilities but will have no impact on earnings, cash flows or shareholders' equity. | |
In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Amendments to the Consolidation Analysis.” The amendments in this update provide guidance on evaluating whether a company should consolidate certain legal entities. In accordance with the guidance, all legal entities are subject to reevaluation under the revised consolidation model. The pronouncement is effective for us in the first quarter of fiscal 2017 with early adoption permitted. We do not believe that this will have a material impact on our consolidated financial statements. | |
In August 2014, the FASB issued Accounting Standards Update No. 2014-15, "Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" (ASU 2014-15), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in the first quarter of fiscal 2017, with early adoption permitted. We do not believe that this will have a material impact on our consolidated financial statements. | |
In June 2014, the FASB issued Accounting Standards Update No. 2014-12, "Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period" (ASU 2014-12). ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in ASC 718, "Compensation - Stock Compensation," as it relates to such awards. ASU 2014-12 is effective for us in our first quarter of fiscal 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. We are currently evaluating the impact of our pending adoption on ASU 2014-12 on our consolidated financial statements. | |
In May 2014, the FASB issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers: Topic 606" (ASU 2014-09), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for us in our first quarter of fiscal 2018 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU 2014-09. We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements. | |
In April 2014, the FASB issued Accounting Standards Update No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" (ASU 2014-08), to change the criteria for determining which disposals can be presented as discontinued operations and enhanced the related disclosure requirements. ASU 2014-08 is effective for us on a prospective basis in our first quarter of fiscal 2016 with early adoption permitted for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. We are currently evaluating the impact of our pending adoption of ASU 2014-08 on our consolidated financial statements. |
Business_Acquisitions_Tables
Business Acquisitions (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Business Combinations [Abstract] | ||||||||||||||||
Components of Acquisition-Related Costs, Net | The components of acquisition-related costs, net are as follows (dollars in thousands): | |||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Transition and integration costs | $ | 2,756 | $ | 4,590 | $ | 6,237 | $ | 8,429 | ||||||||
Professional service fees | 3,485 | 2,399 | 5,686 | 5,738 | ||||||||||||
Acquisition-related adjustments | 282 | (187 | ) | (644 | ) | (4,567 | ) | |||||||||
Total | $ | 6,523 | $ | 6,802 | $ | 11,279 | $ | 9,600 | ||||||||
Included in acquisition-related adjustments for the six months ended March 31, 2014, is income of $7.7 million related to the elimination of contingent liabilities established in the original allocation of purchase price for acquisitions closed in fiscal 2008, following the expiration of the applicable statute of limitations. |
Goodwill_and_Intangible_Assets1
Goodwill and Intangible Assets (Tables) | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||
Changes in Carrying Amount of Goodwill and Intangible Assets | The changes in the carrying amount of goodwill and intangible assets for the six months ended March 31, 2015, are as follows (dollars in thousands): | |||||||
Goodwill | Intangible | |||||||
Assets | ||||||||
Balance at September 30, 2014 | $ | 3,410,893 | $ | 915,483 | ||||
Acquisitions | — | 27,830 | ||||||
Purchase accounting adjustments | (1,788 | ) | (554 | ) | ||||
Amortization | — | (82,917 | ) | |||||
Effect of foreign currency translation | (54,371 | ) | (7,281 | ) | ||||
Balance at March 31, 2015 | $ | 3,354,734 | $ | 852,561 | ||||
Financial_Instruments_and_Hedg1
Financial Instruments and Hedging Activities (Tables) | 6 Months Ended | ||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||
ScheduleOfOutstandingSharesSubjectToSecurityPriceGuarantees [Table Text Block] | The following is a summary of the outstanding shares subject to security price guarantees at March 31, 2015 (dollars in thousands): | ||||||||||||||||||
Issue Date | Number of Shares Issued | Settlement Date | Total Value of Shares on Issue Date | ||||||||||||||||
November 10, 2014 | 288,148 | May 12, 2015 | $ | 4,469 | |||||||||||||||
Quantitative Summary of Fair Value of Derivative Instruments | The following table provides a quantitative summary of the fair value of our derivative instruments as of March 31, 2015 and September 30, 2014 (dollars in thousands): | ||||||||||||||||||
Derivatives Not Designated as Hedges: | Balance Sheet Classification | Fair Value | |||||||||||||||||
31-Mar-15 | 30-Sep-14 | ||||||||||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | $ | 379 | $ | — | ||||||||||||||
Foreign currency contracts | Accrued expenses and other current liabilities | (383 | ) | (272 | ) | ||||||||||||||
Security Price Guarantees | Contingent and deferred acquisition payments | (334 | ) | — | |||||||||||||||
Security Price Guarantees | Accrued expenses and other current liabilities | — | (135 | ) | |||||||||||||||
Net fair value of non-hedge derivative instruments | $ | (338 | ) | $ | (407 | ) | |||||||||||||
Summarized Activity of Derivative Instruments | The following tables summarize the activity of derivative instruments for the three and six months ended March 31, 2015 and 2014 (dollars in thousands): | ||||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | ||||||||||||||||||
Derivatives Not Designated as Hedges | Location of Gain (Loss) Recognized in Income | 2015 | 2014 | 2015 | 2014 | ||||||||||||||
Foreign currency contracts | Other income (expense), net | $ | (12,813 | ) | $ | 2,046 | $ | (19,096 | ) | $ | 6,372 | ||||||||
Security price guarantees | Other income (expense), net | $ | 23 | $ | (72 | ) | $ | (539 | ) | $ | (4,222 | ) | |||||||
Fair_Value_Measures_Tables
Fair Value Measures (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||
Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis at March 31, 2015 and September 30, 2014 consisted of (dollars in thousands): | |||||||||||||||
31-Mar-15 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 275,478 | $ | — | $ | — | $ | 275,478 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Time deposits | — | 53,190 | — | 53,190 | ||||||||||||
Commercial paper, $9,080 at cost (b) | — | 9,087 | — | 9,087 | ||||||||||||
Corporate notes and bonds, $41,838 at cost (b) | — | 41,860 | — | 41,860 | ||||||||||||
Foreign currency exchange contracts(b) | — | 379 | — | 379 | ||||||||||||
Total assets at fair value | $ | 276,478 | $ | 104,516 | $ | — | $ | 380,994 | ||||||||
Liabilities: | ||||||||||||||||
Foreign currency exchange contracts(b) | $ | — | $ | (383 | ) | $ | — | $ | (383 | ) | ||||||
Security price guarantees(c) | — | (334 | ) | — | (334 | ) | ||||||||||
Contingent acquisition payments (d) | — | — | (3,931 | ) | (3,931 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (717 | ) | $ | (3,931 | ) | $ | (4,648 | ) | |||||
30-Sep-14 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 407,749 | $ | — | $ | — | $ | 407,749 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Time deposits(b) | — | 46,604 | — | 46,604 | ||||||||||||
Total assets at fair value | $ | 408,749 | $ | 46,604 | $ | — | $ | 455,353 | ||||||||
Liabilities: | ||||||||||||||||
Foreign currency exchange contracts(b) | $ | — | $ | (272 | ) | $ | — | $ | (272 | ) | ||||||
Security price guarantees(c) | — | (135 | ) | — | (135 | ) | ||||||||||
Contingent acquisition payments (d) | — | — | (6,864 | ) | (6,864 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (407 | ) | $ | (6,864 | ) | $ | (7,271 | ) | |||||
(a) | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||||||||||||||
(b) | The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||||||||||||||
(c) | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | |||||||||||||||
(d) | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. | |||||||||||||||
Changes in Fair Value of Contingent Earn-Out Liabilities | The changes in the fair value of contingent acquisition payment liabilities are as follows (dollars in thousands): | |||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2015 | |||||||||||||||
Balance at beginning of period | $ | 5,440 | $ | 6,864 | ||||||||||||
Earn-out liability established at time of acquisition | (554 | ) | 85 | |||||||||||||
Payments upon settlement | (1,476 | ) | (2,938 | ) | ||||||||||||
Adjustments to fair value included in acquisition-related costs, net | 521 | (80 | ) | |||||||||||||
Balance at end of period | $ | 3,931 | $ | 3,931 | ||||||||||||
Accrued_Expenses_and_Other_Cur1
Accrued Expenses and Other Current Liabilities (Tables) | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Payables and Accruals [Abstract] | ||||||||
Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (dollars in thousands): | |||||||
31-Mar-15 | 30-Sep-14 | |||||||
Compensation | $ | 91,455 | $ | 146,730 | ||||
Cost of revenue related liabilities | 19,632 | 22,340 | ||||||
Accrued interest payable | 15,106 | 15,092 | ||||||
Liability for unsettled share repurchases | 10,465 | — | ||||||
Professional fees | 9,844 | 10,852 | ||||||
Sales and marketing incentives | 8,006 | 10,188 | ||||||
Sales and other taxes payable | 5,916 | 9,367 | ||||||
Acquisition costs and liabilities | 5,494 | 9,307 | ||||||
Facilities related liabilities | 5,207 | 5,720 | ||||||
Other | 8,878 | 11,683 | ||||||
Total | $ | 180,003 | $ | 241,279 | ||||
Deferred_Revenue_Tables
Deferred Revenue (Tables) | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Deferred Revenue [Abstract] | ||||||||
Deferred Revenue | Deferred revenue consisted of the following (dollars in thousands): | |||||||
31-Mar-15 | 30-Sep-14 | |||||||
Current liabilities: | ||||||||
Deferred maintenance revenue | $ | 150,983 | $ | 140,737 | ||||
Unearned revenue | 192,668 | 157,488 | ||||||
Total current deferred revenue | $ | 343,651 | $ | 298,225 | ||||
Long-term liabilities: | ||||||||
Deferred maintenance revenue | $ | 58,412 | $ | 60,398 | ||||
Unearned revenue | 235,742 | 189,481 | ||||||
Total long-term deferred revenue | $ | 294,154 | $ | 249,879 | ||||
Restructuring_and_Other_Charge1
Restructuring and Other Charges, net (Tables) | 6 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||
Accrual Activity Relating to Restructuring and Other Charges | The following table sets forth accrual activity relating to our restructuring reserves for the six months ended March 31, 2015 (dollars in thousands): | |||||||||||||||||||||||
Personnel | Facilities | Total | ||||||||||||||||||||||
Balance at September 30, 2014 | $ | 3,258 | $ | 1,468 | $ | 4,726 | ||||||||||||||||||
Restructuring charges, net | 1,639 | 256 | 1,895 | |||||||||||||||||||||
Cash payments | (4,191 | ) | (1,372 | ) | (5,563 | ) | ||||||||||||||||||
Balance at March 31, 2015 | $ | 706 | $ | 352 | $ | 1,058 | ||||||||||||||||||
Restructuring and Other Charges, Net by Segment | Restructuring charges, net by segment are as follows (dollars in thousands): | |||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | (81 | ) | $ | — | $ | (81 | ) | $ | 186 | $ | — | $ | 186 | ||||||||||
Mobile and Consumer | (125 | ) | (172 | ) | (297 | ) | (12 | ) | — | (12 | ) | |||||||||||||
Enterprise | 71 | — | 71 | 1,568 | — | 1,568 | ||||||||||||||||||
Imaging | (1 | ) | (60 | ) | (61 | ) | 131 | — | 131 | |||||||||||||||
Corporate | 35 | — | 35 | (199 | ) | 45 | (154 | ) | ||||||||||||||||
Total restructuring expense | $ | (101 | ) | $ | (232 | ) | $ | (333 | ) | $ | 1,674 | $ | 45 | $ | 1,719 | |||||||||
Included in restructuring charges, net for the three months ended March 31, 2015, is the benefit resulting from lower charges than originally estimated related to final settlement on abandoned facilities. | ||||||||||||||||||||||||
Six Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | (209 | ) | $ | — | $ | (209 | ) | $ | 400 | $ | — | $ | 400 | ||||||||||
Mobile and Consumer | (113 | ) | (172 | ) | (285 | ) | 190 | — | 190 | |||||||||||||||
Enterprise | 289 | 95 | 384 | 1,745 | — | 1,745 | ||||||||||||||||||
Imaging | 1,479 | 333 | 1,812 | 131 | — | 131 | ||||||||||||||||||
Corporate | 193 | — | 193 | 627 | 2,463 | 3,090 | ||||||||||||||||||
Total restructuring expense | $ | 1,639 | $ | 256 | $ | 1,895 | $ | 3,093 | $ | 2,463 | $ | 5,556 | ||||||||||||
Debt_and_Credit_Facilities_Tab
Debt and Credit Facilities (Tables) | 6 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Borrowing Obligations and Applicable Margin for Borrowings | The applicable margin for the borrowings at March 31, 2015 is as follows: | |||||||
Description | Base Rate Margin | LIBOR Margin | ||||||
Term loans maturing August 2019 | 1.75% | 2.75% | ||||||
Revolving facility due August 2018 | 0.50% - 0.75% (a) | 1.50% - 1.75% (a) | ||||||
(a) | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. | |||||||
At March 31, 2015 and September 30, 2014, we had the following borrowing obligations (dollars in thousands): | ||||||||
31-Mar-15 | 30-Sep-14 | |||||||
5.375% Senior Notes due 2020, net of unamortized premium of $4.2 million and $4.6 million, respectively. Effective interest rate 5.28%. | $ | 1,054,209 | $ | 1,054,601 | ||||
2.75% Convertible Debentures due 2031, net of unamortized discount of $75.7 million and $88.8 million, respectively. Effective interest rate 7.43%. | 614,280 | 601,226 | ||||||
Credit Facility, net of unamortized original issue discount of $0.9 million and $1.0 million respectively. | 474,083 | 476,399 | ||||||
Total long-term debt | $ | 2,142,572 | $ | 2,132,226 | ||||
Less: current portion | 4,834 | 4,834 | ||||||
Non-current portion of long-term debt | $ | 2,137,738 | $ | 2,127,392 | ||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Share-based Compensation [Abstract] | ||||||||||||||||
Stock Based Compensation Included in Consolidated Statements of Operations | The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): | |||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Cost of product and licensing | $ | 96 | $ | 697 | $ | 183 | $ | 962 | ||||||||
Cost of professional services and hosting | 4,729 | 7,199 | 12,352 | 13,818 | ||||||||||||
Cost of maintenance and support | 631 | 406 | 1,574 | 1,190 | ||||||||||||
Research and development | 6,668 | 10,455 | 17,177 | 20,743 | ||||||||||||
Selling and marketing | 7,882 | 10,210 | 20,416 | 25,454 | ||||||||||||
General and administrative | 10,911 | 15,953 | 26,569 | 29,992 | ||||||||||||
Total | $ | 30,917 | $ | 44,920 | $ | 78,271 | $ | 92,159 | ||||||||
Summary of Stock Options Activity | The table below summarizes activity relating to stock options for the six months ended March 31, 2015: | |||||||||||||||
Number of | Weighted | Weighted | Aggregate | |||||||||||||
Shares | Average | Average | Intrinsic | |||||||||||||
Exercise | Remaining | Value(a) | ||||||||||||||
Price | Contractual | |||||||||||||||
Term | ||||||||||||||||
Outstanding at September 30, 2014 | 3,723,342 | $ | 13.46 | |||||||||||||
Exercised | (98,845 | ) | $ | 2.03 | ||||||||||||
Forfeited | (892 | ) | $ | 20.04 | ||||||||||||
Expired | (29,248 | ) | $ | 20.38 | ||||||||||||
Outstanding at March 31, 2015 | 3,594,357 | $ | 13.72 | 1.8 years | $ | 4.7 | million | |||||||||
Exercisable at March 31, 2015 | 3,592,132 | $ | 13.71 | 1.8 years | $ | 4.7 | million | |||||||||
Exercisable at March 31, 2014 | 3,919,399 | $ | 13.39 | 2.6 years | $ | 15 | million | |||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on March 31, 2015 ($14.35) and the exercise price of the underlying options. | |||||||||||||||
Summary of Activity Relating to Restricted Units and Restricted Stock Awards | The table below summarizes activity relating to Restricted Units for the six months ended March 31, 2015: | |||||||||||||||
Number of Shares Underlying Restricted Units — Contingent Awards | Number of Shares Underlying Restricted Units — Time-Based Awards | |||||||||||||||
Outstanding at September 30, 2014 | 5,726,385 | 8,349,107 | ||||||||||||||
Granted | 1,312,530 | 5,551,512 | ||||||||||||||
Earned/released | (1,847,551 | ) | (5,604,407 | ) | ||||||||||||
Forfeited | (603,889 | ) | (321,467 | ) | ||||||||||||
Outstanding at March 31, 2015 | 4,587,475 | 7,974,745 | ||||||||||||||
Weighted average remaining recognition period of outstanding Restricted Units | 1.6 years | 1.6 years | ||||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Units | $57.6 million | $88.1 million | ||||||||||||||
Aggregate intrinsic value of outstanding Restricted Units(a) | $65.8 million | $114.5 million | ||||||||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on March 31, 2015 ($14.35) and the purchase price of the underlying Restricted Units. | |||||||||||||||
Restricted Stock Awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to Restricted Stock Awards for the six months ended March 31, 2015: | ||||||||||||||||
Number of Shares Underlying Restricted Stock | Weighted Average Grant Date Fair Value | |||||||||||||||
Outstanding at September 30, 2014 | 750,000 | $ | 21.28 | |||||||||||||
Vested | (250,000 | ) | $ | 25.8 | ||||||||||||
Outstanding at March 31, 2015 | 500,000 | $ | 19.01 | |||||||||||||
Weighted average remaining recognition period of outstanding Restricted Awards | 0.6 years | |||||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Awards | $4.2 million | |||||||||||||||
Aggregate intrinsic value of outstanding Restricted Awards | $7.2 million | |||||||||||||||
Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units and Restricted Stock Awards Vested | A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Units vested during the periods noted is as follows: | |||||||||||||||
Six Months Ended March 31, | ||||||||||||||||
2015 | 2014 | |||||||||||||||
Weighted-average grant-date fair value per share | $ | 14.87 | $ | 15.26 | ||||||||||||
Total intrinsic value of shares vested (in millions) | $ | 110.9 | $ | 70.2 | ||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Stock Awards vested during the periods noted is as follows: | ||||||||||||||||
Six Months Ended March 31, | ||||||||||||||||
2015 | 2014 | |||||||||||||||
Weighted-average grant-date fair value per share | $ | — | $ | 15.71 | ||||||||||||
Total intrinsic value of shares vested (in millions) | $ | 3.9 | $ | 3.9 | ||||||||||||
Income_Taxes_Tables
Income Taxes (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Income Tax Disclosure [Abstract] | ||||||||||||||||
Components of Benefit from Income Taxes | The components of (loss) income before income taxes are as follows (dollars in thousands): | |||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Domestic | $ | (37,225 | ) | $ | (55,683 | ) | $ | (100,935 | ) | $ | (121,628 | ) | ||||
Foreign | 34,186 | 22,850 | 53,215 | 36,360 | ||||||||||||
(Loss) income before income taxes | $ | (3,039 | ) | $ | (32,833 | ) | $ | (47,720 | ) | $ | (85,268 | ) | ||||
The components of provision from income taxes are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended March 31, | Six Months Ended March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Domestic | $ | 5,832 | $ | 5,250 | $ | 9,634 | $ | 3,795 | ||||||||
Foreign | 5,227 | 1,144 | 7,239 | 5,577 | ||||||||||||
Provision for income taxes | $ | 11,059 | $ | 6,394 | $ | 16,873 | $ | 9,372 | ||||||||
Effective tax rate | (363.9 | )% | (19.5 | )% | (35.4 | )% | (11.0 | )% |
Segment_and_Geographic_Informa1
Segment and Geographic Information and Significant Customers (Tables) | 6 Months Ended | |||||||||||||||
Mar. 31, 2015 | ||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||
Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes | The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): | |||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Segment revenues(a): | ||||||||||||||||
Healthcare | $ | 228,604 | $ | 236,997 | $ | 459,584 | $ | 464,283 | ||||||||
Mobile and Consumer | 116,691 | 107,254 | 224,037 | 219,712 | ||||||||||||
Enterprise | 83,302 | 89,728 | 173,945 | 181,734 | ||||||||||||
Imaging | 59,466 | 55,994 | 119,527 | 114,289 | ||||||||||||
Total segment revenues | 488,063 | 489,973 | 977,093 | 980,018 | ||||||||||||
Acquisition-related revenues | (13,004 | ) | (14,320 | ) | (28,015 | ) | (34,385 | ) | ||||||||
Total consolidated revenues | 475,059 | 475,653 | 949,078 | 945,633 | ||||||||||||
Segment profit: | ||||||||||||||||
Healthcare | 79,842 | 91,477 | 158,120 | 169,937 | ||||||||||||
Mobile and Consumer | 33,816 | 16,697 | 45,509 | 28,830 | ||||||||||||
Enterprise | 19,282 | 18,230 | 44,014 | 40,673 | ||||||||||||
Imaging | 22,080 | 20,704 | 42,008 | 43,384 | ||||||||||||
Total segment profit | 155,020 | 147,108 | 289,651 | 282,824 | ||||||||||||
Corporate expenses and other, net | (35,450 | ) | (30,126 | ) | (71,118 | ) | (61,332 | ) | ||||||||
Acquisition-related revenues and cost of revenues adjustment | (12,088 | ) | (13,037 | ) | (26,378 | ) | (31,869 | ) | ||||||||
Stock-based compensation | (30,917 | ) | (44,920 | ) | (78,271 | ) | (92,159 | ) | ||||||||
Amortization of intangible assets | (40,959 | ) | (41,913 | ) | (82,917 | ) | (84,579 | ) | ||||||||
Acquisition-related costs, net | (6,523 | ) | (6,802 | ) | (11,279 | ) | (9,600 | ) | ||||||||
Restructuring and other charges, net | 333 | (4,719 | ) | (1,895 | ) | (8,556 | ) | |||||||||
Costs associated with IP collaboration agreements | (2,938 | ) | (4,937 | ) | (5,876 | ) | (9,874 | ) | ||||||||
Other expense, net | (29,517 | ) | (33,487 | ) | (59,637 | ) | (70,123 | ) | ||||||||
Loss before income taxes | $ | (3,039 | ) | $ | (32,833 | ) | $ | (47,720 | ) | $ | (85,268 | ) | ||||
(a) | Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. | |||||||||||||||
Classification of Revenue By Major Geographic Areas | Revenue, classified by the major geographic areas in which our customers are located, was as follows (dollars in thousands): | |||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
United States | $ | 352,448 | $ | 346,587 | $ | 700,122 | $ | 689,772 | ||||||||
International | 122,611 | 129,066 | 248,956 | 255,861 | ||||||||||||
Total revenues | $ | 475,059 | $ | 475,653 | $ | 949,078 | $ | 945,633 | ||||||||
Business_Acquisitions_Summary_
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Detail) (USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Sep. 30, 2014 |
Allocation of the purchase consideration: | |
Goodwill | $139.40 |
Identifiable intangible assets | 134.5 |
Weighted average life | 10 years 2 months |
Other Acquisitions [Member] | |
Business Acquisition [Line Items] | |
Payments to Acquire Businesses, Gross | $258.30 |
Business_Acquisitions_Summary_1
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Parenthetical) (Detail) | 12 Months Ended |
Sep. 30, 2014 | |
Business Acquisition [Line Items] | |
Weighted average life | 10 years 2 months |
Business_Acquisitions_Addition
Business Acquisitions (Additional Information) (Detail) (USD $) | 6 Months Ended | 12 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2014 | Sep. 30, 2014 | Mar. 31, 2015 |
Business Acquisition [Line Items] | |||
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $16 | ||
Goodwill | 139.4 | ||
Identifiable intangible assets | 134.5 | ||
Weighted average life | 10 years 2 months | ||
Business Combination Acquisition Related Adjustments | 7.7 | ||
Other Acquisitions [Member] | |||
Business Acquisition [Line Items] | |||
Payments to Acquire Businesses, Gross | $258.30 |
Business_Acquisitions_Componen
Business Acquisitions (Components of Acquisition-Related Costs, Net) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 | |
Business Acquisition [Line Items] | ||||
Business Combination Acquisition Related Adjustments | $7,700,000 | |||
Transition and integration costs | 2,756,000 | 4,590,000 | 6,237,000 | 8,429,000 |
Professional service fees | 3,485,000 | 2,399,000 | 5,686,000 | 5,738,000 |
Business Combination Acquisition Related Adjustments | 282,000 | -187,000 | -644,000 | -4,567,000 |
Business Combination, Acquisition Related Costs | $6,523,000 | $6,802,000 | $11,279,000 | $9,600,000 |
Contingent_Acquisition_Payment
Contingent Acquisition Payments (Detail) (USD $) | Mar. 31, 2015 |
In Millions, unless otherwise specified | |
Business Acquisition, Contingent Consideration [Line Items] | |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $16 |
Changes_in_Carrying_Amount_of_
Changes in Carrying Amount of Goodwill and Intangible Assets (Detail) (USD $) | 6 Months Ended | 1 Months Ended |
Mar. 31, 2015 | Oct. 31, 2014 | |
Goodwill [Roll Forward] | ||
Balance at September 30, 2013 | $3,410,893,000 | $3,410,893,000 |
Acquisitions | 0 | |
Purchase accounting adjustments | -1,788,000 | |
Amortization | 0 | |
Effect of foreign currency translation | -54,371,000 | |
Balance at March 31, 2015 | 3,354,734,000 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Balance at September 30, 2014 | 915,483,000 | 915,483,000 |
Acquisitions | 27,830,000 | |
Purchase accounting adjustments | -554,000 | |
Amortization | -82,917,000 | |
Effect of foreign currency translation | -7,281,000 | |
Balance at March 31, 2015 | 852,561,000 | |
Dragon Consumer Reporting Unit [Member] | ||
Reporting Unit [Line Items] | ||
Goodwill, Transfers | 29,900,000 | |
Enterprise Reporting Unit [Member] | ||
Reporting Unit [Line Items] | ||
Goodwill, Transfers | $10,500,000 |
Financial_Instruments_and_Hedg2
Financial Instruments and Hedging Activities (Additional Information) (Detail) (USD $) | 6 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Sep. 30, 2014 |
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Estimated fair value of long-term debt | 2,220.20 | $2,179.20 |
Long-term debt, face value | 2,215 | 2,217.40 |
Derivatives Not Designated as Hedges | ||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Derivative, Notional Amount | 141.4 | $283.10 |
Derivatives Not Designated as Hedges | Maximum | ||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Term of foreign currency forward contracts | 90 days |
Financial_Instruments_and_Hedg3
Financial Instruments and Hedging Activities (Summary of Outstanding Shares Subject to Security Price Guarantees) (Detail) (Security Price Guarantees Issued Date On November Tenth Twenty Fourteen [Member], USD $) | 6 Months Ended |
In Thousands, except Share data, unless otherwise specified | Mar. 31, 2015 |
Security Price Guarantees Issued Date On November Tenth Twenty Fourteen [Member] | |
Derivative [Line Items] | |
equity issuance, date | 10-Nov-14 |
Stock Issued During Period, Shares, New Issues | 288,148 |
Settlement Dates | 12-May-15 |
Stock Issued During Period, Value, New Issues | $4,469 |
Financial_Instruments_and_Hedg4
Financial Instruments and Hedging Activities (Quantitative Summary of Fair Value of Derivative Instruments) (Detail) (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Derivatives, Fair Value [Line Items] | ||
Net asset (liability) value of non-hedged derivative instruments | ($338) | ($407) |
Foreign currency contracts | Prepaid expenses and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset value of non-hedge derivative instruments | 379 | 0 |
Foreign currency contracts | Accrued Expenses And Other Current Liabilities [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | -383 | -272 |
Security Price Guarantees | Contingent and deferred acquisition payment [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | -334 | 0 |
Security Price Guarantees | Accrued Expenses And Other Current Liabilities [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | $0 | ($135) |
Financial_Instruments_and_Hedg5
Financial Instruments and Hedging Activities (Summarized Activity of Derivative Instruments) (Detail) (Derivatives Not Designated as Hedges, Other income (expense), net, USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Foreign currency contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Amount of Gain (Loss) Recognized in Income | ($12,813) | $2,046 | ($19,096) | $6,372 |
Security price guarantees | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Amount of Gain (Loss) Recognized in Income | $23 | ($72) | ($539) | ($4,222) |
Fair_Value_Measures_Assets_and
Fair Value Measures (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Detail) (USD $) | 6 Months Ended | |||
Mar. 31, 2015 | Sep. 30, 2014 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Document Period End Date | 31-Mar-15 | |||
Fair Value, Measurements, Recurring | ||||
Assets: | ||||
Money market funds | 275,478,000 | [1] | $407,749,000 | [1] |
US government agency securities | 1,000,000 | [1] | 1,000,000 | [1] |
Bank Time Deposits, Fair Value Disclosure | 53,190,000 | 46,604,000 | ||
Commercial Paper, Fair value | 9,087,000 | |||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 41,860,000 | |||
Foreign currency exchange contracts | 379,000 | [2] | ||
Total assets at fair value | 380,994,000 | 455,353,000 | ||
Liabilities: | ||||
Foreign Currency Contracts, Liability, Fair Value Disclosure | -383,000 | [2] | -272,000 | [2] |
Security price guarantees | -334,000 | -135,000 | [3] | |
Contingent earn-out | -3,931,000 | [4] | -6,864,000 | [4] |
Total liabilities at fair value | -4,648,000 | -7,271,000 | ||
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ||||
Assets: | ||||
Money market funds | 275,478,000 | 407,749,000 | ||
US government agency securities | 1,000,000 | 1,000,000 | ||
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | ||
Commercial Paper, Fair value | 0 | |||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 0 | |||
Foreign currency exchange contracts | 0 | |||
Total assets at fair value | 276,478,000 | 408,749,000 | ||
Interest Rate Derivative Liabilities, at Fair Value | 0 | |||
Liabilities: | ||||
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | |||
Security price guarantees | 0 | 0 | ||
Contingent earn-out | 0 | 0 | ||
Total liabilities at fair value | 0 | 0 | ||
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ||||
Assets: | ||||
Money market funds | 0 | 0 | ||
US government agency securities | 0 | 0 | ||
Bank Time Deposits, Fair Value Disclosure | 53,190,000 | 46,604,000 | ||
Commercial Paper, Fair value | 9,087,000 | |||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 41,860,000 | |||
Foreign currency exchange contracts | 379,000 | |||
Total assets at fair value | 104,516,000 | 46,604,000 | ||
Liabilities: | ||||
Foreign Currency Contracts, Liability, Fair Value Disclosure | -383,000 | -272,000 | ||
Security price guarantees | -334,000 | -135,000 | ||
Contingent earn-out | 0 | 0 | ||
Total liabilities at fair value | -717,000 | -407,000 | ||
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ||||
Assets: | ||||
Money market funds | 0 | 0 | ||
US government agency securities | 0 | 0 | ||
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | ||
Commercial Paper, Fair value | 0 | |||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 0 | |||
Foreign currency exchange contracts | 0 | |||
Total assets at fair value | 0 | 0 | ||
Interest Rate Derivative Liabilities, at Fair Value | 0 | |||
Liabilities: | ||||
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | |||
Security price guarantees | 0 | 0 | ||
Contingent earn-out | -3,931,000 | -6,864,000 | ||
Total liabilities at fair value | -3,931,000 | -6,864,000 | ||
Corporate Debt Securities [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Available-for-sale Securities, Amortized Cost Basis | 41,838,000 | |||
Commercial Paper [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Available-for-sale Securities, Amortized Cost Basis | 9,080,000 | |||
Commercial paper, corporate notes and bonds [Member] | ||||
Liabilities: | ||||
Available for sale Securities, Weighted Average Maturity | 1 year 3 months 23 days | |||
[1] | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||
[2] | The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||
[3] | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | |||
[4] | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. |
Fair_Value_Measures_Changes_in
Fair Value Measures (Changes in Fair Value of Contingent Earn-Out Liabilities) (Detail) (USD $) | Mar. 31, 2015 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $16,000,000 |
Balance at beginning of period | 3,931,000 |
Balance at end of period | $3,931,000 |
Accrued_Expenses_and_Other_Cur2
Accrued Expenses and Other Current Liabilities (Detail) (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Payables and Accruals [Abstract] | ||
Compensation | $91,455 | $146,730 |
Cost of revenue related liabilities | 19,632 | 22,340 |
Accrued interest payable | 15,106 | 15,092 |
liability for unsettled share repurchases | 10,465 | 0 |
Accrued Professional Fees, Current | 9,844 | 10,852 |
Sales and marketing incentives | 8,006 | 10,188 |
Sales and other taxes payable | 5,916 | 9,367 |
Accrued Acquisition Costs And Liabilities Current | 5,494 | 9,307 |
Facilities related liabilities | 5,207 | 5,720 |
Other | 8,878 | 11,683 |
Total | $180,003 | $241,279 |
Deferred_Revenue_Detail
Deferred Revenue (Detail) (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Current deferred revenue | $343,651 | $298,225 |
Long-term deferred revenue | 294,154 | 249,879 |
Deferred maintenance revenue | ||
Current deferred revenue | 150,983 | 140,737 |
Long-term deferred revenue | 58,412 | 60,398 |
Unearned revenue | ||
Current deferred revenue | 192,668 | 157,488 |
Long-term deferred revenue | $235,742 | $189,481 |
Restructuring_and_Other_Charge2
Restructuring and Other Charges, net (Accrual Activity Relating to Restructuring and Other Charges) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | $4,726 | |||
Restructuring and other charges, net | -333 | 1,719 | 1,895 | 5,556 |
Cash payments | -5,563 | |||
Balance at March 31, 2015 | 1,058 | 1,058 | ||
Personnel | ||||
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | 3,258 | |||
Restructuring and other charges, net | -101 | 1,674 | 1,639 | 3,093 |
Cash payments | -4,191 | |||
Balance at March 31, 2015 | 706 | 706 | ||
Facilities | ||||
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | 1,468 | |||
Restructuring and other charges, net | -232 | 45 | 256 | 2,463 |
Cash payments | -1,372 | |||
Balance at March 31, 2015 | $352 | $352 |
Restructuring_and_Other_Charge3
Restructuring and Other Charges, net (By Segment) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | $333 | ($1,719) | ($1,895) | ($5,556) |
Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 81 | -186 | 209 | -400 |
Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 297 | 12 | 285 | -190 |
Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | -71 | -1,568 | -384 | -1,745 |
Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 61 | -131 | -1,812 | -131 |
Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | -35 | 154 | -193 | -3,090 |
Personnel | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 101 | -1,674 | -1,639 | -3,093 |
Personnel | Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 81 | -186 | 209 | -400 |
Personnel | Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | -125 | -12 | 113 | -190 |
Personnel | Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | -71 | -1,568 | -289 | -1,745 |
Personnel | Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 1 | -131 | -1,479 | -131 |
Personnel | Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | -35 | 199 | -193 | -627 |
Facilities | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 232 | -45 | -256 | -2,463 |
Facilities | Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 0 | 0 | 0 | 0 |
Facilities | Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 172 | 0 | 172 | 0 |
Facilities | Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 0 | 0 | -95 | 0 |
Facilities | Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 60 | 0 | -333 | 0 |
Facilities | Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | $0 | ($45) | $0 | ($2,463) |
Restructuring_and_Other_Charge4
Restructuring and Other Charges, net (Additional Information) (Detail) (USD $) | 6 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2015 |
Person | |
Restructuring Cost and Reserve [Line Items] | |
Restructuring Charges | $1,900 |
Number of personnel eliminated | 60 |
Personnel | |
Restructuring Cost and Reserve [Line Items] | |
Restructuring Charges | 1,639 |
Facilities | |
Restructuring Cost and Reserve [Line Items] | |
Restructuring Charges | $256 |
Debt_and_Credit_Facilities_Add
Debt and Credit Facilities (Additional Information) (Detail) (USD $) | 6 Months Ended | |
Mar. 31, 2015 | Sep. 30, 2014 | |
Amended Credit Agreement | ||
Debt Instrument [Line Items] | ||
Percentage of Capital Stock of Domestic Subsidiaries Pledged as Collateral | 100.00% | |
Revolving Credit Facility [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, unamortized discount | ($900,000) | ($1,000,000) |
Line of Credit Facility, Maximum Borrowing Capacity | 75,000,000 | |
Credit facility, outstanding | 474,083,000 | 476,399,000 |
Letters of credit, outstanding | 5,400,000 | |
Credit facility, commitment fee percentage for unused capacity | 0.38% | |
Revolving Credit Facility [Member] | Minimum | ||
Debt Instrument [Line Items] | ||
Credit facility, commitment fee percentage for unused capacity | 0.25% | |
Revolving Credit Facility [Member] | Maximum | ||
Debt Instrument [Line Items] | ||
Credit facility, commitment fee percentage for unused capacity | 0.38% | |
Term Loan | ||
Debt Instrument [Line Items] | ||
Debt Covenants, Percentage of Net Cash Proceeds from Asset Sales | 100.00% | |
Debt Covenants, Percentage of Net Cash Proceeds from Issuance or Incurrence of Debt | 100.00% | |
Debt Covenants, Percentage of Extraordinary Receipts | 100.00% | |
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt instrument, unamortized discount | -75,700,000 | -88,800,000 |
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% |
Debt Instrument, Maturity Date | 2031 | |
2.75% Convertible Debentures due August 15, 2027 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt instrument, unamortized discount | 0 | 0 |
Debt Instrument, Interest Rate, Effective Percentage | 7.30% | 7.30% |
Debt Instrument, Maturity Date | 2027 | |
5.375% Senior Notes due August 15, 2020 | ||
Debt Instrument [Line Items] | ||
Senior notes, principal amount | 1,054,209,000 | 1,054,601,000 |
Debt instrument, stated interest rate | 5.38% | 5.38% |
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% |
Debt Instrument, Maturity Date | 2020 | |
Unamortized Premium | ($4,200,000) | ($4,600,000) |
Voting Equity Interests [Member] | Amended Credit Agreement | ||
Debt Instrument [Line Items] | ||
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 65.00% | |
Non-voting Equity Interests [Member] | Amended Credit Agreement | ||
Debt Instrument [Line Items] | ||
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 100.00% |
Debt_and_Credit_Facilities_Bor
Debt and Credit Facilities (Borrowing Obligations) (Detail) (USD $) | Mar. 31, 2015 | Sep. 30, 2014 |
Debt Instrument [Line Items] | ||
Total long-term debt | $2,142,572,000 | $2,132,226,000 |
Less: current portion | 4,834,000 | 4,834,000 |
Non-current portion of long-term debt | 2,137,738,000 | 2,127,392,000 |
5.375% Senior Notes due August 15, 2020 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 5.38% | 5.38% |
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% |
Unamortized Premium | 4,200,000 | 4,600,000 |
Senior Notes, net of unamortized premium | 1,054,209,000 | 1,054,601,000 |
2.75% Convertible Debentures due August 15, 2027 | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt Instrument, Interest Rate, Effective Percentage | 7.30% | 7.30% |
Debt instrument, unamortized discount | 0 | 0 |
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% |
Debt instrument, unamortized discount | -75,700,000 | -88,800,000 |
Convertible Debentures, net of unamortized discount | 614,280,000 | 601,226,000 |
Revolving Credit Facility [Member] | ||
Debt Instrument [Line Items] | ||
Debt instrument, unamortized discount | -900,000 | -1,000,000 |
Credit Facility, net of unamortized original issue discount of $0.9 million and $1.0 million respectively. | $474,083,000 | $476,399,000 |
Debt_and_Credit_Facilities_App
Debt and Credit Facilities (Applicable Margin for Borrowings) (Detail) (USD $) | 6 Months Ended | ||
Mar. 31, 2015 | Sep. 30, 2014 | ||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 2.75% | ||
Credit Facility, net of unamortized original issue discount of $0.9 million and $1.0 million respectively. | $475,000,000 | ||
Revolving Credit Facility [Member] | |||
Line of Credit Facility [Line Items] | |||
Line of Credit Facility, Maximum Borrowing Capacity | 75,000,000 | ||
Letters of credit, outstanding | 5,400,000 | ||
Credit Facility, net of unamortized original issue discount of $0.9 million and $1.0 million respectively. | $474,083,000 | $476,399,000 | |
Credit facility, commitment fee percentage for unused capacity | 0.38% | ||
Revolving Credit Facility [Member] | Minimum | |||
Line of Credit Facility [Line Items] | |||
Credit facility, commitment fee percentage for unused capacity | 0.25% | ||
Revolving Credit Facility [Member] | Maximum | |||
Line of Credit Facility [Line Items] | |||
Credit facility, commitment fee percentage for unused capacity | 0.38% | ||
Base Rate Margin | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 1.75% | ||
Base Rate Margin | Revolving facility due March 2015 | Minimum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 0.50% | [1] | |
Base Rate Margin | Revolving facility due March 2015 | Maximum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 0.75% | [1] | |
LIBOR Margin | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 2.75% | ||
Debt Instrument, Interest Rate, Effective Percentage | 2.93% | ||
LIBOR Margin | Revolving facility due March 2015 | Minimum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 1.50% | [1] | |
LIBOR Margin | Revolving facility due March 2015 | Maximum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 1.75% | [1] | |
[1] | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. |
Stockholders_Equity_Details
Stockholders' Equity (Details) (USD $) | 6 Months Ended | 23 Months Ended | ||
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2015 | Apr. 29, 2015 | Apr. 29, 2013 |
Stockholders Equity Note [Line Items] | ||||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | $500 | $500 | ||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | 168.9 | 168.9 | ||
Stock Repurchased During Period, Shares | 8.6 | 20 | ||
Stock Repurchased During Period, Value | $120.30 | $331.10 |
Net_Loss_Per_Share_Additional_
Net Loss Per Share (Additional Information) (Detail) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Earnings Per Share, Basic and Diluted [Abstract] | ||||
Anti-dilutive common equivalent shares excluded from computation of diluted net income (loss) per share | 9.7 | 12.5 | 11.2 | 13.1 |
StockBased_Compensation_Includ
Stock-Based Compensation (Included in Consolidated Statements of Operations) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | $30,917 | $44,920 | $78,271 | $92,159 |
Cost of product and licensing | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 96 | 697 | 183 | 962 |
Cost of professional services and hosting | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 4,729 | 7,199 | 12,352 | 13,818 |
Cost of maintenance and support | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 631 | 406 | 1,574 | 1,190 |
Research and development | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 6,668 | 10,455 | 17,177 | 20,743 |
Selling and marketing | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 7,882 | 10,210 | 20,416 | 25,454 |
General and administrative | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | $10,911 | $15,953 | $26,569 | $29,992 |
StockBased_Compensation_Additi
Stock-Based Compensation (Additional Information) (Detail) (USD $) | 6 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $1.20 | $2.10 |
Restricted Stock Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Purchase price for restricted units, vested | $0.00 |
StockBased_Compensation_Summar
Stock-Based Compensation (Summary of Stock Options Activity) (Detail) (USD $) | 6 Months Ended | |
In Millions, except Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Number of Shares | ||
Outstanding at September 30, 2014 | 3,723,342 | |
Exercised | -98,845 | |
Forfeited | -892 | |
Expired | -29,248 | |
Outstanding at March 31, 2015 | 3,594,357 | |
Exercisable | 3,592,132 | 3,919,399 |
Weighted Average Exercise Price | ||
Outstanding at September 30, 2014 | $13.46 | |
Exercised | $2.03 | |
Forfeited | $20.04 | |
Expired | $20.38 | |
Outstanding at March 31, 2015 | $13.72 | |
Exercisable | $13.71 | $13.39 |
Weighted Average Remaining Contractual Term | ||
Outstanding at March 31, 2015 | 1 year 9 months | |
Exercisable | 1 year 9 months | 2 years 7 months |
Aggregate Intrinsic Value | ||
Outstanding at March 31, 2015 | $4.70 | |
Exercisable | $4.70 | $15 |
StockBased_Compensation_Summar1
Stock-Based Compensation (Summary of Stock Options Activity) (Parenthetical) (Detail) (USD $) | 6 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Share-based Compensation [Abstract] | ||
Closing market value of common stock | $14.35 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $1.20 | $2.10 |
StockBased_Compensation_Summar2
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Detail) (USD $) | 6 Months Ended |
In Millions, except Share data, unless otherwise specified | Mar. 31, 2015 |
Restricted Stock Awards | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Purchase price for restricted units, vested | $0.00 |
Restricted Units, Outstanding [Roll Forward] | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -250,000 |
Outstanding at March 31, 2015 | 500,000 |
Number of Shares Underlying Restricted Units — Contingent Awards | |
Restricted Units, Outstanding [Roll Forward] | |
Outstanding at September 30, 2014 | 5,726,385 |
Granted | 1,312,530 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -1,847,551 |
Forfeited | -603,889 |
Outstanding at March 31, 2015 | 4,587,475 |
Weighted average remaining recognition period of outstanding Restricted Units | 1 year 7 months |
Unearned stock-based compensation expense of outstanding Restricted Units | $57.60 |
Aggregate intrinsic value of outstanding Restricted Units(a) | 65.8 |
Number of Shares Underlying Restricted Units — Time-Based Awards | |
Restricted Units, Outstanding [Roll Forward] | |
Outstanding at September 30, 2014 | 8,349,107 |
Granted | 5,551,512 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -5,604,407 |
Forfeited | -321,467 |
Outstanding at March 31, 2015 | 7,974,745 |
Weighted average remaining recognition period of outstanding Restricted Units | 1 year 7 months |
Unearned stock-based compensation expense of outstanding Restricted Units | 88.1 |
Aggregate intrinsic value of outstanding Restricted Units(a) | $114.50 |
StockBased_Compensation_Summar3
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Parenthetical) (Detail) (USD $) | Mar. 31, 2015 |
Share-based Compensation [Abstract] | |
Closing market value of common stock | $14.35 |
StockBased_Compensation_Summar4
Stock-Based Compensation (Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units Vested) (Detail) (Restricted Stock Units, USD $) | 6 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average grant-date fair value per share | $14.87 | $15.26 |
Total intrinsic value of shares vested (in millions) | $110.90 | $70.20 |
StockBased_Compensation_StockB
Stock-Based Compensation Stock-Based Compensation (Restricted Stock Awards) (Details) (USD $) | 6 Months Ended | ||
In Millions, except Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Sep. 30, 2014 |
Restricted Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $21.28 | ||
Outstanding at September 30, 2014 | 750,000 | ||
Weighted average remaining recognition period of outstanding Restricted Units | 0 years 7 months | ||
Unearned stock-based compensation expense of outstanding Restricted Units | $4.20 | ||
Aggregate intrinsic value of outstanding Restricted Units(a) | 7.2 | ||
Weighted Average Grant Date Fair Value, Granted | $0 | $15.71 | |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value | 3.9 | 3.9 | |
Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted Average Grant Date Fair Value, Granted | $14.87 | $15.26 | |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value | 110.9 | 70.2 | |
Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $19.01 | ||
Outstanding at March 31, 2015 | 500,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -250,000 | ||
Weighted Average Grant Date Fair Value, Vested | $25.80 | ||
Number of Shares Underlying Restricted Units — Contingent Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Outstanding at September 30, 2014 | 5,726,385 | ||
Granted | 1,312,530 | ||
Forfeited | 603,889 | ||
Outstanding at March 31, 2015 | 4,587,475 | ||
Weighted average remaining recognition period of outstanding Restricted Units | 1 year 7 months | ||
Unearned stock-based compensation expense of outstanding Restricted Units | 57.6 | ||
Aggregate intrinsic value of outstanding Restricted Units(a) | $65.80 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -1,847,551 |
Income_Taxes_Components_of_Ben
Income Taxes (Components of Benefit from Income Taxes) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 | |
Income Tax Disclosure [Abstract] | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $2,500,000 | |||
Domestic Tax Expense (Benefit) | 5,832,000 | 5,250,000 | 9,634,000 | 3,795,000 |
Foreign | 5,227,000 | 1,144,000 | 7,239,000 | 5,577,000 |
Provision for income taxes | $11,059,000 | $6,394,000 | $16,873,000 | $9,372,000 |
Effective tax rate | -363.90% | -19.50% | -35.40% | -11.00% |
Income_Taxes_Additional_Inform
Income Taxes (Additional Information) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | |||
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 | Sep. 30, 2014 | |
Business Acquisition [Line Items] | |||||
Income taxes associated with uncertain tax position | $22,100,000 | $22,100,000 | $21,200,000 | ||
U.S. federal statutory income tax rate | 35.00% | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | 2,500,000 | ||||
Effective tax rate | -363.90% | -19.50% | -35.40% | -11.00% | |
Provision for income taxes | $11,059,000 | $6,394,000 | $16,873,000 | $9,372,000 |
Income_Taxes_Loss_income_befor
Income Taxes (Loss) income before income taxes (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Income Tax Disclosure [Abstract] | ||||
Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($37,225) | ($55,683) | ($100,935) | ($121,628) |
Income (Loss) from Continuing Operations before Income Taxes, Foreign | 34,186 | 22,850 | 53,215 | 36,360 |
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest | ($3,039) | ($32,833) | ($47,720) | ($85,268) |
Income_Taxes_Deferred_Tax_Expe
Income Taxes Deferred Tax Expense (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 | |
Income Taxes [Line Items] | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $2,500,000 | |||
Provision for income taxes | 11,059,000 | 6,394,000 | 16,873,000 | 9,372,000 |
Goodwill [Member] | ||||
Income Taxes [Line Items] | ||||
Provision for income taxes | $3,500,000 | $7,100,000 |
Commitments_and_Contingencies_
Commitments and Contingencies (Details) | 6 Months Ended |
Mar. 31, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Indemnification term for former officers and directors | 6 years |
Segment_and_Geographic_Informa2
Segment and Geographic Information and Significant Customers (Additional Information) (Detail) | 6 Months Ended |
Mar. 31, 2015 | |
Segment | |
Segment Reporting [Abstract] | |
Number of reportable business segments | 4 |
Segment_and_Geographic_Informa3
Segment and Geographic Information and Significant Customers (Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Segment Reporting Information [Line Items] | ||||
Revenue | $488,063 | $489,973 | $977,093 | $980,018 |
Revenues | 475,059 | 475,653 | 949,078 | 945,633 |
Segment profit | 155,020 | 147,108 | 289,651 | 282,824 |
Corporate expenses and other, net | -35,450 | -30,126 | -71,118 | -61,332 |
Acquisition-related revenues and cost of revenues adjustment | -12,088 | -13,037 | -26,378 | -31,869 |
Stock-based compensation | -30,917 | -44,920 | -78,271 | -92,159 |
Amortization of intangible assets | -40,959 | -41,913 | -82,917 | -84,579 |
Acquisition-related costs, net | -6,523 | -6,802 | -11,279 | -9,600 |
Restructuring and other charges, net | 333 | -4,719 | -1,895 | -8,556 |
Costs associated with IP collaboration agreements | -2,938 | -4,937 | -5,876 | -9,874 |
Other expense, net | -29,517 | -33,487 | -59,637 | -70,123 |
Loss before income taxes | -3,039 | -32,833 | -47,720 | -85,268 |
Healthcare | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 228,604 | 236,997 | 459,584 | 464,283 |
Segment profit | 79,842 | 91,477 | 158,120 | 169,937 |
Mobile and Consumer | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 116,691 | 107,254 | 224,037 | 219,712 |
Segment profit | 33,816 | 16,697 | 45,509 | 28,830 |
Enterprise | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 83,302 | 89,728 | 173,945 | 181,734 |
Segment profit | 19,282 | 18,230 | 44,014 | 40,673 |
Imaging | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 59,466 | 55,994 | 119,527 | 114,289 |
Segment profit | 22,080 | 20,704 | 42,008 | 43,384 |
Acquisition-related revenues | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | ($13,004) | ($14,320) | ($28,015) | ($34,385) |
Segment_and_Geographic_Informa4
Segment and Geographic Information and Significant Customers (Classification of Revenue by Major Geographic Areas) (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2014 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $488,063 | $489,973 | $977,093 | $980,018 |
Total revenues | 475,059 | 475,653 | 949,078 | 945,633 |
UNITED STATES | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | 352,448 | 346,587 | 700,122 | 689,772 |
International [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $122,611 | $129,066 | $248,956 | $255,861 |